The Role of Redox-Regulating Enzymes in Inoperable Breast Cancers Treated with Neoadjuvant Chemotherapy

An unexplored role for Peroxiredoxin in exercise-induced redox signalling?

(2016) Alex J. Wadley et al.   Redox Biology

The thioredoxin system in breast cancer cell invasion and migration

(2016) Maneet Bhatia et al.   Redox Biology

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2015) E. Senkus et al.   ANNALS OF ONCOLOGY

Crystal structure of fully oxidized human thioredoxin

(2015) Jungwon Hwang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Interplay between cytosolic disulfide reductase systems and the Nrf2/Keap1 pathway

(2015) Edward E. Schmidt   BIOCHEMICAL SOCIETY TRANSACTIONS

Keap1 expression has independent prognostic value in pancreatic adenocarcinomas

(2015) Joel Isohookana et al.   Diagnostic Pathology

Expression and clinical value of peroxiredoxin-1 in patients with pancreatic cancer

(2015) C.-Y. Cai et al.   EJSO

Reactive oxygen species mediate Terbufos-induced apoptosis in mouse testicular cell lines via the modulation of cell cycle and pro-apoptotic proteins

(2015) Jui-Hsiang Hung et al.   ENVIRONMENTAL TOXICOLOGY

Comparison of immunoreactive score, HER2/neuscore and H score for the immunohistochemical evaluation of somatostatin receptors in bronchopulmonary neuroendocrine neoplasms

(2015) Elisa Specht et al.   HISTOPATHOLOGY

Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms?

(2015) V.A. Carozzi et al.   NEUROSCIENCE LETTERS

Over-expression of Thioredoxin-1 mediates growth, survival, and chemoresistance and is a druggable target in diffuse large B-cell lymphoma

(2015) Changping Li et al.   Oncotarget

Nrf2, the master redox switch: The Achilles' heel of ovarian cancer?

(2014) Monique G.P. van der Wijst et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

(2014) Patricia Cortazar et al.   LANCET

Induction of Peroxiredoxin 1 by Hypoxia Regulates Heme Oxygenase-1 via NF-κB in Oral Cancer

(2014) Min Zhang et al.   PLoS One

Diagnostic and prognostic significance of peroxiredoxin 1 expression in human hepatocellular carcinoma

(2013) Qi-Kai Sun et al.   MEDICAL ONCOLOGY

Expression of peroxiredoxins I and IV in multiple myeloma: association with immunoglobulin accumulation

(2013) Ana Paula Dias Demasi et al.   VIRCHOWS ARCHIV

Teaching the basics of redox biology to medical and graduate students: Oxidants, antioxidants and disease mechanisms

(2013) Balaraman Kalyanaraman   Redox Biology

Expression of Peroxiredoxin 1, 2, 3, and 6 Genes in Cancer Cells during Drug Resistance Formation

(2012) E. V. Kalinina et al.   BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE

Peroxiredoxin 1 knockdown potentiates  -lapachone cytotoxicity through modulation of reactive oxygen species and mitogen-activated protein kinase signals

(2012) T. He et al.   CARCINOGENESIS

AberrantKeap1methylation in breast cancer and association with clinicopathological features

(2012) Raffaela Barbano et al.   Epigenetics

Redox regulation of cancer cell migration and invasion

(2012) Lalchhandami Tochhawng et al.   MITOCHONDRION

The prognostic and predictive power of redox protein expression for anthracycline-based chemotherapy response in locally advanced breast cancer

(2012) Caroline M Woolston et al.   MODERN PATHOLOGY

Physiological Roles of Mitochondrial Reactive Oxygen Species

(2012) Laura A. Sena et al.   MOLECULAR CELL

Prdx1 deficiency in mice promotes tissue specific loss of heterozygosity mediated by deficiency in DNA repair and increased oxidative stress

(2012) Vamsi Rani et al.   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS

Redox regulation of cell migration and adhesion

(2012) Thomas Ryan Hurd et al.   TRENDS IN CELL BIOLOGY

Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas

(2011) Peeter Karihtala et al.   BMC CANCER

Keap1 Mutations and Nrf2 Pathway Activation in Epithelial Ovarian Cancer

(2011) P. A. Konstantinopoulos et al.   CANCER RESEARCH

Peroxiredoxins are involved in metallothionein protection from doxorubicin cardiotoxicity

(2011) Li Jing et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Oligomeric peroxiredoxin-I is an essential intermediate for p53 to activate MST1 kinase and apoptosis

(2011) A Morinaka et al.   ONCOGENE

Discovery of the Negative Regulator of Nrf2, Keap1: A Historical Overview

(2010) Ken Itoh et al.   ANTIOXIDANTS & REDOX SIGNALING

High Levels of Nrf2 Determine Chemoresistance in Type II Endometrial Cancer

(2010) T. Jiang et al.   CANCER RESEARCH

Nrf2 and Keap1 Abnormalities in Non-Small Cell Lung Carcinoma and Association with Clinicopathologic Features

(2010) L. M. Solis et al.   CLINICAL CANCER RESEARCH

Loss of Keap1 Function Activates Nrf2 and Provides Advantages for Lung Cancer Cell Growth

(2008) T. Ohta et al.   CANCER RESEARCH

Genetic Alteration of Keap1 Confers Constitutive Nrf2 Activation and Resistance to Chemotherapy in Gallbladder Cancer

(2008) Tatsuhiro Shibata et al.   GASTROENTEROLOGY